# Cipla Limited - Inspection Records

Source: https://www.globalkeysolutions.net/companies/cipla-limited/6b5864ed-07a2-4861-b424-021018d4f7e9

> Inspection records and compliance data for Cipla Limited in Goa, None. Access full analysis and detailed observations.

---

## Details

- Name: Cipla Limited
- FEI Number: 3004081307
- City: Goa
- State: None
- Country Name: India
- Address Line 1: L129 - 146 S - 103 - 105 S - 107 - 112 L147 - L147 1
- Address Line 2: Vasco Da Gama
- Zip Code: None
- Facility Type: Drug Manufacturer
- Business Operations: FDF MANUFACTURE

## Related Documents

- [483 - Cipla Limited - 2024-06-21](https://www.globalkeysolutions.net/records/483/cipla-limited/8db1e1bc-0bc5-4334-9558-e7aa003c3b7d) — source: FDA, date: June 21, 2024
- [483 - Cipla Limited - 2024-06-21](https://www.globalkeysolutions.net/records/483/cipla-limited/6e6db655-6ac9-49bd-9d30-2442d2bf857f) — source: FDA, date: June 21, 2024
- [FDA Inspection 1240813 - Cipla Limited - 2024-06-21](https://www.globalkeysolutions.net/records/fda_inspections/cipla-limited/8bbdb860-88af-47ff-ac3a-04cb8bedbcad) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 21, 2024
- [483 - Cipla Limited - 2022-08-26](https://www.globalkeysolutions.net/records/483/cipla-limited/3c4414ab-af3a-425d-bb60-2b91ddd03159) — source: FDA, date: August 26, 2022
- [483 - Cipla Limited - 2022-08-26](https://www.globalkeysolutions.net/records/483/cipla-limited/4847f9f1-e066-460e-aa6f-a79ada9678a4) — source: FDA, date: August 26, 2022
- [FDA Inspection 1178952 - Cipla Limited - 2022-08-26](https://www.globalkeysolutions.net/records/fda_inspections/cipla-limited/dc52b0e2-2947-4e2d-9bdf-1a9dc7fb515e) — classification: Official Action Indicated (OAI), source: FDA, date: August 26, 2022
- [483 - Cipla Limited - 2019-09-27](https://www.globalkeysolutions.net/records/483/cipla-limited/df1fd743-d55e-4cd8-aa93-f66bb318c12d) — source: FDA, date: September 27, 2019
- [483 - Cipla Limited - 2019-09-27](https://www.globalkeysolutions.net/records/483/cipla-limited/6ab9733d-f9eb-40af-874b-7ca1a2214662) — source: FDA, date: September 27, 2019
- [FDA Inspection 1103305 - Cipla Limited - 2019-09-27](https://www.globalkeysolutions.net/records/fda_inspections/cipla-limited/3d4ad184-ec01-4b07-8d4c-c5a5edc56a1a) — classification: Official Action Indicated (OAI), source: FDA, date: September 27, 2019
- [FDA Inspection 1103305 - Cipla Limited - 2019-09-27](https://www.globalkeysolutions.net/records/fda_inspections/cipla-limited/8e4dda74-73d5-4f2e-853a-19cf3d2511d5) — classification: Official Action Indicated (OAI), source: FDA, date: September 27, 2019
- [483 - Cipla Limited - 2019-01-28](https://www.globalkeysolutions.net/records/483/cipla-limited/96151c31-a5c8-4cfa-b564-ee38cfa14dad) — source: FDA, date: January 28, 2019
- [FDA Inspection 1078911 - Cipla Limited - 2019-01-28](https://www.globalkeysolutions.net/records/fda_inspections/cipla-limited/f442d154-0a0c-46ea-ba3d-7b670aa57332) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 28, 2019
- [FDA Inspection 1078911 - Cipla Limited - 2019-01-28](https://www.globalkeysolutions.net/records/fda_inspections/cipla-limited/40022821-c763-46fa-bc75-58ecaf478d52) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 28, 2019
- [483 - Cipla Limited - 2018-09-28](https://www.globalkeysolutions.net/records/483/cipla-limited/19271680-9b57-470b-88a8-053b854fc6d1) — source: FDA, date: September 28, 2018
- [FDA Inspection 1069950 - Cipla Limited - 2018-09-28](https://www.globalkeysolutions.net/records/fda_inspections/cipla-limited/fd66a0e6-fa12-4219-bb1a-572cd01b3c0f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 28, 2018
- [483 - Cipla Limited - 2018-01-25](https://www.globalkeysolutions.net/records/483/cipla-limited/00e64667-a769-4e4b-bbed-c435ef1a7485) — source: FDA, date: January 25, 2018
- [FDA Inspection 1015874 - Cipla Limited - 2017-06-16](https://www.globalkeysolutions.net/records/fda_inspections/cipla-limited/0671a700-583b-47a7-8a57-ffe202f53df4) — classification: No Action Indicated (NAI), source: FDA, date: June 16, 2017
- [FDA Inspection 1015874 - Cipla Limited - 2017-06-16](https://www.globalkeysolutions.net/records/fda_inspections/cipla-limited/0dc5ed23-04e8-408c-811f-a18647f3e1b5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 16, 2017
- [483 - Cipla Limited - 2016-08-30](https://www.globalkeysolutions.net/records/483/cipla-limited/72b519eb-58af-4d80-991a-d0eb593f645f) — source: FDA, date: August 30, 2016
- [FDA Inspection 995628 - Cipla Limited - 2016-08-30](https://www.globalkeysolutions.net/records/fda_inspections/cipla-limited/5c4dc6a2-f5d1-4e44-b51f-454266a3627b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 30, 2016

## Related Companies

- [Jubilant HollisterStier LLC](https://www.globalkeysolutions.net/companies/jubilant-hollisterstier-llc/2f8cb6dd-3555-4528-a2d6-d3b845d229ba)
- [Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)](https://www.globalkeysolutions.net/companies/vetter-pharma-fertigung-gmbh-co-kg-ravensburg-mooswiesen/d0287c3d-c544-40de-aece-ba713025286c)
- [Novitium Pharma LLC](https://www.globalkeysolutions.net/companies/novitium-pharma-llc/056d60b0-f42a-4b34-987f-749ffff0520a)
- [Kenvue Brands LLC](https://www.globalkeysolutions.net/companies/kenvue-brands-llc/69c27fd1-bbb9-4c3a-bbb5-4ac86be8e574)
- [Pharmco Laboratories Inc.](https://www.globalkeysolutions.net/companies/pharmco-laboratories-inc/b34e3481-0ea5-433a-9e03-ce66b44df443)
- [Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site)](https://www.globalkeysolutions.net/companies/qilu-pharmaceutical-co-ltd-high-tech-zone-site/94263442-b5c4-4df8-b563-30ae0b9a4206)
- [Allergan Sales, LLC](https://www.globalkeysolutions.net/companies/allergan-sales-llc/dced41da-32c6-41b1-829c-6287550c2c71)
- [CoreRX Inc.](https://www.globalkeysolutions.net/companies/corerx-inc/cca4f858-9ccd-498a-893b-22c5d29559aa)
- [Mylan Laboratories Limited](https://www.globalkeysolutions.net/companies/mylan-laboratories-limited/4fd10a2e-3696-4bd0-82aa-e875143028c0)
- [Seqirus Inc](https://www.globalkeysolutions.net/companies/seqirus-inc/0debebe6-6f57-40d3-abf9-5914fb18b58a)

## Related Officers

- [Director, Enterprise Regulatory Compliance](https://www.globalkeysolutions.net/people/nicholas-a-violand/c0c3ee7a-8adb-43d2-974c-06220ef8e8eb)
- [Consumer Safety Officer](https://www.globalkeysolutions.net/people/rajiv-r-srivastava/05b42bfd-0cf4-42ce-89e1-b81bf36eaa17)
- [Thomas J. Arista](https://www.globalkeysolutions.net/people/thomas-j-arista/37905892-3285-4f3f-b4b5-f963df1e59d3)
- [Cheryl A. Clausen](https://www.globalkeysolutions.net/people/cheryl-a-clausen/2306b2bc-8f01-4f77-ba2d-1a3186d6f6fc)
- [Angela Glenn](https://www.globalkeysolutions.net/people/angela-glenn/5ba5e1e2-883b-42c4-aae0-3564820723e8)